结缔组织生长因子是一种新型促抑郁因子
研究基于重性抑郁障碍患者杏仁核中结缔组织生长因子(CTGF)表达上调及动物模型证据,提出CTGF是促抑郁分子。在大鼠中,社会挫败应激和幼年FGF2治疗分别升高和降低CTGF表达,CTGF给药增加抑郁样行为,而抗CTGF抗体FG-3019具有抗抑郁作用。
要点
- 重性抑郁障碍患者杏仁核CTGF表达显著升高。
- CTGF给药增加大鼠抑郁样行为,抗CTGF抗体FG-3019急慢性治疗均抗抑郁。
- CTGF是潜在的新型抗抑郁治疗靶点。
核心结论
- CTGF是首个被发现的促抑郁分子,可作为新型治疗开发靶点。
研究设计与样本
- 研究检测了重性抑郁障碍患者死后杏仁核CTGF基因表达,并在远交大鼠及两种选择性培育的新奇寻求/焦虑行为差异大鼠品系中随访。
- 研究评估了社会挫败和幼年成纤维细胞生长因子2治疗对CTGF表达的影响,以及抗CTGF抗体FG-3019改变CTGF表达和情绪行为的能力。
主要发现
- 在人类杏仁核中,重性抑郁障碍患者CTGF表达较对照受试者显著增加。
- 成年培育低反应大鼠齿状回CTGF表达较培育高反应大鼠显著增加。
- 培育低反应大鼠中社会挫败应激显著增加齿状回CTGF表达。
- 幼年FGF2治疗降低成年齿状回CTGF表达,该治疗可终身减少焦虑样行为。
- 远交大鼠中CTGF给药增加抑郁样行为。
临床怎么用
- CTGF及其下游通路可能成为新型抗抑郁药物开发的靶点,抗CTGF抗体FG-3019在动物模型中显示抗抑郁潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While downregulation of several growth factors in major depressive disorder is well established, less attention has been paid to the upregulation of other growth factors. Yet, upregulated growth factors may offer better therapeutic targets. We show that connective tissue growth factor (CTGF) represents a target based on its upregulation in major depressive disorder and studies in animal models implicating it in negative affect. METHODS: CTGF gene expression was first evaluated in the postmortem human amygdala. The findings were followed up in outbred rats and in two rat lines that were selectively bred for differences in novelty-seeking and anxiety behavior (bred low responders and bred high responders). We studied the impact of social defeat and early-life treatment with fibroblast growth factor 2 on CTGF expression. Finally, we assessed the ability of an anti-CTGF antibody (FG-3019) to alter CTGF expression and emotionality. RESULTS: In the human amygdala, CTGF expression was significantly increased in major depressive disorder compared with control subjects. CTGF expression was also significantly increased in the dentate gyrus of adult bred low responders compared with bred high responders. Social defeat stress in bred low responders significantly increased CTGF expression in the dentate gyrus. Early-life fibroblast growth factor 2, a treatment that reduces anxiety-like behavior throughout life, decreased CTGF expression in the adult dentate gyrus. In outbred rats, CTGF administration increased depression-like behavior. Chronic treatment with FG-3019 decreased CTGF expression, and acute and chronic treatment was antidepressant. CONCLUSIONS: This study is the first to implicate CTGF as a prodepressant molecule that could serve as a target for the development of novel therapeutics.
引用
- Turner CA, Sharma V, Hagenauer MH, et al. Connective Tissue Growth Factor Is a Novel Prodepressant. Biol Psychiatry. 2018. PMID: 29861095. doi:10.1016/j.biopsych.2018.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。